Decoy Therapeutics Inc. Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Decoy Therapeutics Inc. is a Cambridge, Massachusetts-based biotechnology research company focused on engineering peptide conjugate therapies. Its platform blends AI-guided design with rapid, scalable manufacturing enabled by a proprietary single-shot synthesis approach to accelerate drug development. The firm is pursuing a new class of antivirals with broad activity, a single drug capable of addressing multiple pathogens, and peptide drug conjugates that target GPCRs for treating GI tumors. 

The company seeks to make medicines that are accessible and affordable for people around the world. Recent developments include advancing Designable Multi-Antiviral candidates toward Phase 1 and Phase 2a human studies and partnering with hVIVO Group to support translational modeling, regulatory strategy, and early clinical planning. With a small to mid-sized footprint, Decoy operates in the biotechnology research arena at the intersection of computational design and peptide therapeutics.

Get verified Decoy Therapeutics Inc. emails free

Company overview Employee directory